BioSpace News Archive

Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) (“Kintara” or the “Company”) (Nasdaq: KTRA) announced today that Saiid Zarrabian , Chief Executive Officer of Kintara, will give a virtual corporate presentation at the LD Micro 500 taking place online on Thursday, September 3, 2020 at 4:00 PM ET followed by a liv

Agilum, Inc., a leader in advanced healthcare analytics solutions, recently announced a collaboration with Meadows Regional Medical Center (Meadows) in Vidalia, Georgia, to identify cost savings and growth opportunities through Agilum’s advanced analytics platform and Agilum Healthcare Intelligence services team.

Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a pioneering publication in the prestigious Journal of the American College of Cardiology (JACC) on the use of Stereotaxis’ robotic technology to treat pulmonary hypertension.

Synthego, the genome engineering company, today announced that it raised $100 million in a Series D financing led by new investor Wellington Management, co-led by RA Capital Management and 8VC.

Premier Anesthesia , a national leader and specialist in anesthesia practice management, today announced the appointment of its new president, Preston W. Smith , JD, FACHE. Serving the market for nearly two dec

PDL BioPharma, Inc. (“PDL” or the “Company”) (Nasdaq: PDLI) announces that its majority owned medical device subsidiary, LENSAR, Inc. (“LENSAR”), has filed a registration statement on Form 10 with the Securities and Exchange Commission relating to a potential spin-off of LENSAR from PDL.

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, is scheduled for a presentation at the 25th Annual Conference of the Chinese Biopharmaceutical Association-USA (CBA) to be held online August 29-30, 2020.

Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of chronic inflammatory lung diseases, announced the addition of Rich Mattingly to the Board of Directors.

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announces today that Dr. William F. DeGrado has joined the Company as a Scientific Advisor.

Today, Versant Health, a leading managed vision care company, announced a collaboration with Befitting, an innovative, fast-growing eyewear provider, to bring vision care to workplaces through on-site optical clinics